TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMNM

Immunome Inc

Healthcare · Biotechnology

22.30$ -7.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMNM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – 100.0% 100.0% 100.0% 100.0%
– – – – 9.5% 5.2% 23.2% 42.6%
– – – – -9.5% 100.0% 100.0% 57.4%
– – – – 351.2% 164.7% 1,432.8% 2,511.6%
– – – – 205.7% 140.2% 364.5% 630.6%
– – – – 556.8% 881.4% 3,482.4% 3,142.2%
– – – – -556.8% -781.4% -3,382.4% -3,084.8%
– – – – 0.1% – – –
– – – – -556.8% -761.9% -3,240.4% -3,060.0%
– – – – 9.3% 4.0% -3,240.4% –
– – – – -556.8% -761.9% -3,240.4% -3,060.0%
– – – – -547.2% -199.7% -1,674.1% -3,017.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?